Aspergillus is one of the most diverse genera, and it is chemically profound and known to produce many biologically active secondary metabolites. In the present study, a new aspochalasin H1 (1), together with nine known compounds (2–10), were isolated from a Hawaiian plant-associ-ated endophytic fungus Aspergillus sp. FT1307. The structures were elucidated using nuclear magnetic resonance (NMR) (1H,1H-1H COSY, HSQC, HMBC, ROESY and 1D NOE), high-resolution electrospray ionization mass spectroscopy (HRESIMS), and comparisons with the reported litera-ture. The absolute configuration of the new compound was established by electronic circular di-chroism (ECD) in combination with NMR calculations. The new compound contains an epoxide moiety and an adjacent trans-diol, which has not been reported before in the aspochalasin family. The antibacterial screening of the isolated compounds was carried out against pathogenic bacteria (Staphylococcus aureus, Methicillin-resistant S. aureus and Bacillus subtilis). The antiproliferative activity of compounds 1–10 was evaluated against human breast cancer cell lines (MCF-7 and T46D) and ovarian cancer cell lines (A2780).
CITATION STYLE
Qader, M., Zaman, K. A. U., Hu, Z., Wang, C., Wu, X., & Cao, S. (2021). Aspochalasin h1: A new cyclic aspochalasin from hawaiian plant-associated endophytic fungus aspergillus sp. ft1307. Molecules, 26(14). https://doi.org/10.3390/molecules26144239
Mendeley helps you to discover research relevant for your work.